Shares of Ondine Biomedical Inc. (LON:OBI – Get Free Report) were down 4% during mid-day trading on Tuesday . The company traded as low as GBX 6 ($0.08) and last traded at GBX 6 ($0.08). Approximately 26,019 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 258,805 shares. The stock had previously closed at GBX 6.25 ($0.08).
Ondine Biomedical Stock Up 3.3 %
The company has a market cap of £17.19 million, a P/E ratio of -200.00 and a beta of 0.10. The company has a debt-to-equity ratio of 1,847.37, a current ratio of 0.80 and a quick ratio of 8.26. The company has a 50 day moving average of GBX 6.80 and a 200-day moving average of GBX 7.28.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Featured Articles
- Five stocks we like better than Ondine Biomedical
- ESG Stocks, What Investors Should Know
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- The Risks of Owning Bonds
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- CD Calculator: Certificate of Deposit Calculator
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
